▶주메뉴 바로가기
▶본문 바로가기
Korean firms Genexine and SCM Life science announced on Feb. 13 that they have jointly acquired US biotech firm Argos Therapeutics for around 12.5 billion won (US$ 11.14 million) through an auction...
Korean biotech firm Bridge Biotherapeutics is aiming to get listed on the second-tier KOSDAQ market this year, having picked KB Securities and Daishin Securities as its IPO manager, according to comp...
Korean drug developer Samsung Bioepis announced Feb. 11 that it has inked a partnership with Chinese private equity firm C-Bridge Capital. “We expect C-Bridge to be a great partner for our business ...
Shares of Daewoong Pharmaceutical have been rallying since the company announced on Jan. 1 that its botulinum toxin Nabota received marketing authorization from the US Food and Drug Administration. ...
New drug developer Voronoi is seeking to raise fresh funds worth 100 billion won (US$89 million) ahead of a potential initial public offering, according to news reports on Feb. 8. Established in 201...
Daewoong Pharmaceutical Chairman Jeon Seung-ho on Feb. 1 strongly refuted allegations by its rivals that it stole manufacturing secrets to develop botulinum toxin Nabota. The announcement came after...
[THE INVESTOR] Korean drug maker KyungDong Pharmaceutical said on Feb. 1 that it has invested 1 billion won (US$894,694) in a biotech and health care related startup focused fund led by venture capi...
[THE INVESTOR] Korean 3D bio-printer maker Rokit has secured 11 billion won (US$9.89 million) in funding from KB Investment, Korea Development Bank and DAYLI Partners, according to sources on Jan.31...
[THE INVESTOR] Korean pharmaceutical firm Samsung Bioepis saw its accumulated sales in the European market hit US$545.2 million last year, data showed on Jan. 30. Sales of three biosimilar produ...
[THE INVESTOR] Genosco, a US-based subsidiary of Korean bio company Oscotec, is gearing up to go public, according to industry sources on Jan. 28. The company recently sent out a request for propos...
[THE INVESTOR] LG Household & Health Care said on Jan. 24 its net profit jumped 12 percent on-year fueled by the popularity of its luxury cosmetics brands. Its net profit came to 692 billion won...
[THE INVESTOR] Korean firm Bio Leaders announced on Jan. 23 that it will set up a biotech incubating entity in Israel with venture capital firm Yozma Group. “The official contract to establish the ...
[THE INVESTOR] Hanmi Pharmaceutical said on Jan. 23 that its partner Eli Lilly would hand back its licensed new drug candidate BTK inhibitor in rheumatoid arthritis and its commercialization rights....
[THE INVESTOR] Exports of drug-manufacturing technologies by Korean pharmaceutical and bio companies reached nearly 5.3 trillion won (US$4.70 billion) in 2018, government data showed on Jan. 22. ...
[THE INVESTOR] A Seoul court approved on Jan. 22 a request by Samsung BioLogics to put on hold the execution of penalties by the financial watchdog for the company’s suspected accounting irregularit...
Proptech startup Kasa Korea attracts W9.2b in series B funding
Korean lenders struggle with New York hotel-retail project investment
Netmarble launches storytelling game BTS Universe Story, second collaboration with BTS
Coupang delves into computer parts biz, outcompeting go-betweens
How once rising sports platform TLX Pass fell
W520b per BTS member? Market worth of K-pop stars in limelight as agency’s IPO nears
Litigations pile pressure on Mirae Asset Group
LG Chem to decide acquisition of Nissan factory in Spain within this month
September 28, 2020
